Solventum Corporation (SOLV) — 分析摘要
Solventum Corporation(SOLV)的市值为13.41十亿美元,最近一年的营收同比增长了+0.9%。净利润率为18.7%。当前市盈率为9.4倍。
核心要点
- 营收同比变化+0.9%
- 净利润率18.7%
- 市盈率9.4倍
与SURGICAL & MEDICAL INSTRUMENTS & APPARATUS板块的其他公司相比,SOLV的营收增长为+0.9%,市盈率为9.4倍。
Solventum Corporation (SOLV)
更新 — ET · 来源 POLYGON
红旗与风险提示重点关注
当前存在需要关注的风险信号,应与估值结果一并解读。
最新报表显示自由现金流为负。
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.
行业
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
员工人数
20,000
总部
EAGAN, MN
Exchange
XNYS
需要至少 3 年年度财务数据来评估竞争壁垒。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。